2022 NICE 技术鉴定指南:瑞卢戈利-雌二醇-醋酸炔诺酮用于治疗中度至重度子宫肌瘤症状 [TA832]

2022-10-19 英国国家卫生与临床优化研究所 NICE官网

关于瑞卢戈利-雌二醇-醋酸炔诺酮(Ryeqo) 治疗育龄成人子宫肌瘤中度至重度症状的循证建议。

中文标题:

2022 NICE 技术鉴定指南:瑞卢戈利-雌二醇-醋酸炔诺酮用于治疗中度至重度子宫肌瘤症状 [TA832]

英文标题:

Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids Technology appraisal guidance [TA832]

发布日期:

2022-10-19

简要介绍:

关于瑞卢戈利-雌二醇-醋酸炔诺酮(Ryeqo) 治疗育龄成人子宫肌瘤中度至重度症状的循证建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 NICE 技术鉴定指导:瑞卢戈利-雌二醇-醋酸炔诺酮用于治疗中度至重度子宫肌瘤症状 [TA832].pdf)] GetToolGuiderByIdResponse(projectId=1, id=537c11c002ea059e, title=2022 NICE 技术鉴定指南:瑞卢戈利-雌二醇-醋酸炔诺酮用于治疗中度至重度子宫肌瘤症状 [TA832], enTitle=Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids Technology appraisal guidance [TA832], guiderFrom=NICE官网, authorId=0, author=, summary=关于瑞卢戈利-雌二醇-醋酸炔诺酮(Ryeqo) 治疗育龄成人子宫肌瘤中度至重度症状的循证建议。, cover=https://img.medsci.cn/Random/pexels-photo-3873143.jpeg, journalId=0, articlesId=null, associationId=2005, associationName=英国国家卫生与临床优化研究所 , associationIntro=英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence), copyright=0, guiderPublishedTime=Wed Oct 19 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #000000;">关于瑞卢戈利-雌二醇-醋酸炔诺酮(Ryeqo) 治疗育龄成人子宫肌瘤中度至重度症状的循证建议。</span></p>, tagList=[TagDto(tagId=2245, tagName=子宫肌瘤)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2109, appHits=26, showAppHits=0, pcHits=314, showPcHits=2083, likes=0, shares=2, comments=3, approvalStatus=1, publishedTime=Wed Oct 26 10:11:00 CST 2022, publishedTimeString=2022-10-19, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Oct 20 00:48:32 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 05:09:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 NICE 技术鉴定指导:瑞卢戈利-雌二醇-醋酸炔诺酮用于治疗中度至重度子宫肌瘤症状 [TA832].pdf)])
2022 NICE 技术鉴定指导:瑞卢戈利-雌二醇-醋酸炔诺酮用于治疗中度至重度子宫肌瘤症状 [TA832].pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2097257, encodeId=62e6209e25738, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec6b8403022, createdName=ms3000001290699304, createdTime=Sat Oct 29 14:54:57 CST 2022, time=2022-10-29, status=1, ipAttribution=)]
    展开1条回复